May 2003
Volume 44, Issue 13
ARVO Annual Meeting Abstract  |   May 2003
Clinical Trial on the Use of Autologous Cultured Conjunctival Epithelium for Pterygium Surgery
Author Affiliations & Notes
  • J. Li
    Stem Cell, Singapore Eye Res Inst, Singapore, Singapore
  • H. Cajucom-Uy
    Singapore National Eye Center, Singapore, Singapore
  • C. Gomezperalta
    Singapore National Eye Center, Singapore, Singapore
  • J. Theng
    Singapore National Eye Center, Singapore, Singapore
  • L. Ang
    Singapore National Eye Center, Singapore, Singapore
  • D. Tan
    Depart of Ophthalmology, National University of Singapore, Singapore, Singapore
  • Footnotes
    Commercial Relationships  J. Li, None; H. Cajucom-Uy, None; C. Gomezperalta, None; J. Theng, None; L. Ang, None; D. Tan, None.
  • Footnotes
    Support  SERI Pilot
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1363. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. Li, H. Cajucom-Uy, C. Gomezperalta, J. Theng, L. Ang, D. Tan; Clinical Trial on the Use of Autologous Cultured Conjunctival Epithelium for Pterygium Surgery . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1363.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To evaluate ex-vivo cultured autologous conjunctival tissue equivalent as a conjunctival replacement following pterygium excision Methods: Superior forniceal conjunctival biopsies (1mm x 3 mm) were obtained from patients 2 weeks prior to pterygium surgery. Biopsies were cultured on human amniotic membrane (HAM) in KGM without serum. Cells reached confluence by day 10-12, and subsequent proliferation, stratification and differentiation occurred. At day 14, pterygium surgery was performed – after excision of the pterygium, the autologous multi-layered conjunctival equivalent was sutured over the excised pterygium bed with 10-0 vicryl sutures, and an additional amniotic membrane graft was applied on top as a protective patch. The latter was removed 4 days post-op and patients were followed up at regular intervals up to 12 months. Results: 23 primary pterygium excisions were performed in 22 eyes. In all cases, the transplantation of autologous conjunctival equivalents was successful, with intact cultured epithelium noted over the graft bed upon the removal of the amniotic membrane patch. Ocular surface inflammation and other complications were minimal. However, at the mean follow-up of 9 months (range of 6 months to 1 year), pterygium recurrence occurred in 8 eyes (34.7%). Conclusions: The development of a conjunctival tissue equivalent by ex-vivo expansion of autologous human conjunctival epithelial cells on HAM results in a tissue equivalent which can be transplanted. Pterygium recurrence rates with this tissue equivalent appears to be lower than simple bare sclera excision, but higher as compared to that of pterygium excision with conjunctival autografting, and are similar to conventional amniotic membrane transplantation, with the added advantage that no epithelial defect exists immediately following surgery.

Keywords: Pterygium • transplantation • conjunctiva 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.